AVH 6.48% $2.63 avita medical inc.

interview with rajiv sood on sound medicine, page-3

  1. 10,009 Posts.
    Great interview for the knockers here to listen to.

    Still learning just how good this technology is.


    FDA are excited and taking a lot of notice.

    As I posted earlier each differant use gets quicker to proceed.

    Scar study 2012, FDA approvals June 2013.

    Burns Trials end 2013 and FDA soon after.

    SKIN OFF the SHELF 2nd generation technology far more uses than at present.

    Very excitement but he potential for other uses is great.

    Makes that European Patent look valuable.,

 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.